SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 206 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,031,000
+102.2%
52,389
+125.8%
0.02%
+111.1%
Q2 2021$510,000
-51.1%
23,200
-47.1%
0.01%
-50.0%
Q1 2021$1,043,000
-8.1%
43,852
+1.1%
0.02%
-14.3%
Q4 2020$1,135,000
+162.7%
43,377
+74.9%
0.02%
+61.5%
Q3 2020$432,00024,8000.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders